Evidence-Based Complementary and Alternative Medicine

Evidence-Based Complementary and Alternative Medicine / 2019 / Article

Review Article | Open Access

Volume 2019 |Article ID 7526098 | 8 pages | https://doi.org/10.1155/2019/7526098

Advances in Research on the Protective Mechanisms of Traditional Chinese Medicine (TCM) in Islet β Cells

Academic Editor: Jae Youl Cho
Received24 Jan 2019
Revised16 Jun 2019
Accepted30 Jul 2019
Published21 Aug 2019

Abstract

The dysfunction and decreased number of islet β cells are central to the main pathogenesis of diabetes. Improving islet β cell function and increasing the number of β cells are effective approaches to treat diabetes and constitute the main direction of diabetes drug development. The role of Chinese medicine in the treatment of diabetes began to be recognized. In recent years, Chinese medicine monomers have been found to increase insulin synthesis and secretion, reduce β cell-apoptosis, and protect the function of β cells. The results of in vivo animal experiments and in vitro studies on insulinoma cells also suggested TCMs could promote the proliferation of pancreatic islet β cells and induce other cells differentiation or transdifferentiation to islet β cells. Thereby, they may play a role in the treatment of diabetes. In this paper, we will review islet β cell protection with TCMs and the related mechanisms found in recent studies. An in-depth explanation of the role of TCM in islet β cell protection can provide a theoretical basis and research ideas for the development of TCM-based diabetes treatment drugs.

1. Introduction

According to the WHO, the number of patients with type 2 diabetes mellitus (T2DM) will reach 300 million by 2025. Islet β cell function failure is the core principle of diabetes pathogenesis and the pathophysiological basis for the occurrence and development of the disease. Insulin function failure include decrease in the number of islet β cells, defect of insulin secretion and synthesis of mature insulin. In traditional Chinese medical science, diabetes is called consumptive thirst (XIAO KE). T2DM is categorized as “Xiao Ke” in TCM mentioned in “Huang Di Nei Jing Su Wen” (Pre-Qin Dynasty to Han Dynasty). TCM theorizes that the internal organ weakness, excessive intake of fat and sugar, and mood disorders are the main causes of “Xiao Ke.” The pathogenesis involves an insufficiency of Yin and excessive dryness in vivo, and its governance involves clearing the lungs, moistening dryness, and invigorating the lungs and kidneys. The key etiology of diabetes mellitus included phlegm, heat, dryness, and blood stasis, and the diseased organs were the spleen, lung, stomach, and kidney. Therefore, Chinese medicine often treats diabetes by Triple-jiao deficiencies argument. Diabetes is classified into three types in Chinese medicine including damp-heat trapping spleen, gastrointestinal heat retention, and dry-heat damaging Yin. At present, it is believed that islet β cell damage is mainly caused by qi, blood, and a Yin Yang deficiency, complicated by damp-turbid phlegm, heat, and heat retention. As a complementary and alternative medicine, traditional Chinese medicine (TCM), which has been practiced for thousands of years, has been shown to possess satisfactory clinical effectiveness for diabetes mellitus and its complications, using medications such as Gegen Qinlian Decoction [1], JinQi Jiangtang (JQJT) [2], and Xiaokeping (XKP) [3]. Pueraria (Ge Gen), Astragali (Huang Qi), ginseng (Ren Sheng), digitalis (Di Huang), Anemarrhena (Zhi Mu), Berberine (Ber) (Huang Lian), rhubarb (Da Huang), and other TCMs often have a hypoglycemic effect. There are currently more than 100 types of Chinese medicines that treat diabetes. Huangqi (“Gan” flavor) Bunge and Huanglian (“Ku” flavor) are some of the most frequently prescribed herbs [4]. At present, the active ingredients of TCMs, such as alkaloids, polysaccharides, flavonoids, terpenoids, and saponins, are widely studied [5]. This paper aims to summarize the mechanisms of TCM that protect β cells and the prospects for future research.

2. Improvement in Insulin Secretion in Islet β Cells

2.1. Promotion of Insulin Synthesis and Secretion from Islet β Cells

In both type 1 (T1D) and type 2 diabetes (T2D), the deterioration of glycemic control over time is primarily caused by an inadequate mass and progressive dysfunction of β cell, leading to the impaired insulin secretion. The beta cell senses an elevated level of glucose in the plasma by glucokinase. Glucose enters the tricarboxylic acid cycle (TCA) through solute carrier family 2 (facilitated glucose transporter), resulting in the productin of NADH and FADH2 which promote the ATP production. The rise of the ATP : ADP ratio in the cytoplasm closes the plasmalemmal ATP-sensitive potassium channel (KATP). This results in an influx of Ca2+ into the cell that triggers the exocytosis of insulin granules [6].

Studies have shown that ginsenosides can regulate islet β cell mitochondrial function, increase ATP content, reduce UCP2 content, and increase insulin synthesis and secretion. Ginsenoside Rb2 [7](0.5 μg/mL) can promote insulin synthesis, and ginsenoside Rg3 [8](10 μM) increases insulin secretion by INS-1 cells in a high-glucose environment by 47%. Guavenoic acid (GA) [9] (1 nmol/L) promotes the synthesis and secretion of insulin, possibly via downregulation of PTP1b mRNA and upregulation of the PPAR-γ and PDX-1 genes. Guava leaf extract (GLE) [10] may improve the ability of islet β cells to secrete insulin and may ameliorate oxidative stress in islet β cells.

Berberine [11] can increase the expression of the HNF-1α/PDX-1 pathway and insulin secretion, and this effect becomes larger with increasing concentrations. Baicalein (Huangqin) [12] regulates insulin secretion by inhibiting regulation of the intracellular Ca2+ concentration in islet β cells by voltage-dependent K+ channels in the cell membrane. Resveratrol and curcumin [13] can regulate the expression and activity of phosphodiesterases (PDEs), increase the level of cAMP, and stimulate insulin secretion. Syzygium cumini (L.)–(Myrtaceae) [14] stimulates and modulates insulin release from islet β cells.

2.2. Promotion of Proinsulin Cleavage into Insulin

Proinsulin is an insulin precursor synthesized in the endoplasmic reticulum. It is folded into active insulin by modification and shearing by a series of enzymes [15]. The presence of unfolded or misfolded insulin increases the level of nonnaturally folded polypeptide in the endoplasmic reticulum, thereby causing an imbalance of proinsulin homeostasis, an increased proinsulin/insulin ratio, a decrease in active insulin, and islet β cell dysfunction [16]. Lycium barbarum polysaccharides [17] increase the transcription and expression of proinsulin genes and proteins as well as the transformation of proinsulin into mature insulin.

3. Increasing Islet β Cell Mass

There emerged a consensus that progressive β-cell decline is a characteristic of islet pathology in type 2 diabetes, and restoring an effective β-cell mass is a therapy for diabetes. β cell mass is dictated by a dynamic balance between neogenesis, proliferation, and apoptosis. Several TCMs have been implicated to promote the proliferation and regeneration of pancreatic islet β cells in in vivo animal experiments and in vitro studies on insulinoma cells.

3.1. Promotion of β Cell Proliferation

Studies have shown that Salidroside (Hongjingtian) [18] promotes the mRNA expression of insulin, PDX-1, GLP-1R, and other genes, reduces the level of IL-1β, and promotes the proliferation of β cells. Cortex Lycii (Digupi) (2 g/L) [19] increased the proliferation rate of islet β cells and inhibited the apoptosis of islet β cells. Portulaca oleracea L. (POP I) [20] activates JNK, PDX-1, PPARγ, and ERK, which affects islet β cell mitosis and promotes cell proliferation. Puerarin [21] can upregulate the expression of PDX-1 and promote the proliferation of islet β cells. Baicalein [22] can increase islet β cell mass in mice. Baicalein-treated diabetic mice displayed fewer apoptotic islet β cells and increased viability of clonal islet β cells and human islet cells.

3.2. Induction of Stem Cell Differentiation to Islet β Cells

Stem cells, including embryonic and adult stem cells, have the ability to renew and undergo multipotent differentiation. Pancreatic duct epithelial cells have stem cell properties [23]. Tripterygium wilfordii polysaccharide (TWP) [24] can induce islet stem cells to differentiate into spherical islet cell structures that produce an elongated tubule connected to the extracellular environment through the expression of β cell functional proteins. This finding indicates that TWP can induce islet stem cells to differentiate into β cell-containing islet cell clusters when cultured in vitro. Resveratrol (Baililu) [25] induces embryonic stem cells and the pluripotent stem cell line (hiPSC) MSUH-001 to differentiate into cells expressing specific protein markers of islet β cell function, such as PDX-1, that have an insulin secretion function. Differentiated cells accumulate in islet-like clusters when transplanted into mice with streptozotocin- (STZ-) induced diabetes. The cells secrete insulin and decrease blood glucose of STZ-treated mice. It indicated that resveratrol can promote stem cell differentiated to islet β cell and improves β cell maturation. In another study, it has been found Syzygium cumini (L.) Skeels SC2 [26] could induce β cell neogenesis in islets of STZ-treated mice.

3.3. Transformation of Islet α Cells into Islet β Cells

The epithelium of the pancreas includes β cells, duct cells, acinar cells, and α cells. When pancreatic damage, metabolic stress, and genetic manipulation occur, other pancreatic epithelial cells may be induced to transdifferentiate into β cells, which may then be induced to differentiate or dedifferentiate into immature β cells [27]. Islet α and β cells are derived from the same progenitor cells and express homologous proteins that sense blood glucose levels and promote hormone release, but α cells have the opposite effect on regulating blood glucose levels. Studies have shown that when the Pax4 gene is ectopically expressed, α cells are induced to differentiate into β cells [28]. Pax4 and Arx are the main regulatory genes that induce the transformation of α cells into β cells, and Arx represents the main trigger of α cell-mediated β-like cell regeneration. Artemisinin (Qinghao) [29] increases GABA signaling, and artemether induces ARX transport from the nucleus to the cytoplasm, eliminates ARX from chromatin, and prevents α cells from secreting glucagon. The α cells acquire the characteristics of β cell and then transform into mature β cells with insulin-secreting function.

3.4. Reduction of β Cell Apoptosis

Apoptosis plays important roles in the pathophysiology of T2DM, which resulted in defective insulin secretion and loss of β-cell mass. β-cell apoptosis is mediated through a milliard of caspase family cascade machinery in T2DM. Hyperglycemia-induced β-cell apoptosis has been extensively studied on the balance of proapoptotic Bcl-2 proteins (Bad, Bid, Bik, and Bax) and antiapoptotic Bcl family (Bcl-2 and Bcl-xL) toward apoptosis in vitro isolated islets and insulinoma cell culture. Many pathways, for example, PI3K/AKT, MAPK, and autophagy, involved in apoptosis. There are several kinds of TCMs for treating T2DM, and their mechanisms to lower blood glucose levels include reduction of β cell apoptosis.

Ginsenoside Rg3 [30] can inhibit β cell apoptosis through activating phosphorylation of ERK and p38 MAPK or regulating P44/42 MAPK activation in the β cells. Red ginseng [31] can inhibit the expression of bcl-2, reduce the level of Bax and the activity of caspase-3, reduce the production of proinflammatory cytokines, and inhibit cell apoptosis in β cells of CsA-induced injury. Panax notoginseng saponins (PNS) [32] can upregulate the expression of mir-181b and caspase-3 and increase the expression of bcl-2 and activation of the PI3K-AKT-mTOR pathway, which blocks the expression of the autophagy gene beclin-1 and the autophagy membrane marker LC3-II, thereby reducing apoptosis and autophagy. Berberine [11] can reduce the expression of PTEN, activate the PI3K/Akt signaling pathway, decrease the expression of caspase-3, and significantly reduce the rate of apoptosis. Puerarin [21] and Cortex Mori Radicis with drug serum [33] may downregulate caspase-3 expression, upregulate bcl-2, downregulate Bax expression, and inhibit islet cell apoptosis through the PI3K/Akt pathway. Ophiopogonis Radix [34] protects islet β cells by inhibiting the expression of NF-κB to reduce apoptosis. The Jin Li Da (JLD) granules contain over a dozen Chinese medicinal herbs (CHM) [35], including ginseng (Renshen), puerarin (Gegen), Coptis chinensis (Huanglian), and Radix polygonati officinalis (Yuzhu). JLD might decrease β cell apoptosis through AMP-activated protein kinase activation.

3.5. Maintenance of Islet Cell Structure Integrity

TCMs can protect and repair the structural integrity of islet β cells. The number of islet and endocrine cells in a diabetic model treated with total flavonoids of Lycium barbarum (TFLB) [36] was increased compared to that of the control group, and the islet cell volume was slightly increased. In addition, the number of vacuolar cells decreased, the cell arrangement was uniform, and the structure and morphology were normal. In red ginseng-treated [31] islet cells with CsA-induced injury, the islet size was increased, insulin immunoreactivity was enhanced, islet cell morphology was well preserved, the islet cell boundary was irregular, and vacuolization was reduced. After treatment with puerarin, oleanolic acid, and astragaloside [37], the islet cells were structurally intact, and the islet cell boundary was clear and similar to the normal structure. In the ginsenoside Rg1-treated group [38], the islet cell volume was increased, the areas of islet cells were significantly increased, mitochondria were slightly swollen, the crista were expanded in the endoplasmic reticulum, and Golgi body expansion was obviously reduced. The endocrine β cell morphology and the number of secretory granules were similar to those of normal cells, and aging characteristics were not obvious. Administration of Astragalus total saponins and curcumin in a ratio of 3 : 7 obviously reduced the pathological changes of pancreatic tissue [39]. GLE-treated [10] diabetic rats had islet cells with normal granules and exhibited cell hyperplasticity.

4. Reduction of Oxidative Stress (OS) Damage in Islet β Cells

Insulin secretion abnormalities, high glucose, fat accumulation toxicity, apoptosis, and inflammatory reactions cause increases in highly active ROS, such as H2O2 and RNS. Under these conditions, the activity of SOD, CAT, GSH-Px, and other antioxidants is inhibited and the antioxidant enzyme level in islet β cells is decreased, which resulted in the defect of repairing DNA after oxidative damage ROS can directly damage islet β cells, promote apoptosis, and affect the insulin signal transduction pathway, indirectly inhibiting islet β cell function. The flavonoids, polysaccharides, and glycosides in TCMs can enhance antioxidant enzyme activity, reduce peroxide accumulation, block the protein kinase C signaling pathway and cytokine activity, and repair OS damage in islet β cells.

Cordyceps sinensis (CS) [40]can decrease NO and ROS production, reduce Ca2+ concentration, and enhance the expression of UCP-2 protein in islet cells damaged by IL-1β, effectively scavenge free radicals, and reduce oxidative damage. Puerarin [41] reduces the MDA content, increases SOD activity, reduces serum levels of PGE2, ET, H2O2, and NO, and inhibits the mRNA and protein expression of ICAM-1, NOX2, and NOX4. Salidroside [42] can downregulate TXNIP mRNA and upregulate TRX mRNA levels, resulting in low ROS levels. Total flavonoids of Lycium barbarum (TFLB) [36] can increase SOD and GSH levels and reduce MDA content. Anoectochilus roxburghii [43] can remove DPPH and ABTS, thereby reducing NO production, and the expression of iNOS, COX-2, and IL-1β reduces OS. Oleanolic acid [37] inhibits α-glucosidase activity, OS, and the inflammatory reaction. Cinnamaldehyde [44] directly increases the antioxidant enzyme activity of islet cells and reduces the production of free radicals. GA [45] can inhibit the production of ROS in INS-1 cells and alleviate OS. Many TCMs can exert their biological functions through the JNK signaling pathway to reduce oxidative stress. GinsenosideRb1 [46] inhibits the JNK signaling pathway, as well as JNK1 and c-Jun expression in STZ-induced diabetic rats, thereby resulting in negative regulation of the expression of the inflammatory molecules IL-6, IL-1β, and TNF-α, which reduces inflammation and OS damage. POP I [20] downregulates the expression of the JNK1, P38, and ERK proteins in the JNK pathway and alleviates the damage induced by oxygen-free radicals. Crude Portulaca Oleracea L. Polysaccharide (CPOP) [47], which is an antioxidant with an antidiabetic and anti-inflammatory effect, reduces MDA content and increases SOD activity in the diabetic rats. Mogroside [48] can significantly reduce the ROS content in NIT-1 cells, upregulate the expression of GLUT-2 and the pyruvate kinase gene, inhibit the activation of the JNK signal transduction pathway, and reverse the effect of Foxo1, which slows OS damage and protects islet secretion. Curcumin [49, 50] antagonistically binds to TLR-4 and prevents caspase-8 from activating apoptotic DNA fragments, reducing the number of cells affected by proinflammatory cytokines (such as GM-CSF, G-CSF, and IL-6), NK T cells, and macrophage infiltration. Administration of 4–8 g/kg of Polygonatum odoratum [51] can reduce interferon IFN-γ and IL-4 levels, inhibit inflammatory cell infiltration and the polarization of Th1 cells, and reduce the oxidation of islet β cells after stimulation.

5. Promotion of GLP-1 Secretion

GLP-1 is a peptide hormone secreted by intestinal L cells and acts on islet β cells to promote insulin gene transcription, increase insulin synthesis and secretion, stimulate the proliferation and differentiation of β cells, and inhibit β cell apoptosis. Several TCMs have been demonstrated to simulate GLP1 secretion. The active ingredients of Rhizoma coptidis [52] can increase the secretion of GLP-1. In vivo and in vitro experiments on rats and STC-1 cell lines have demonstrated that emodin [53] promotes the secretion of GLP-1 by regulating PPARδ in a dose-dependent manner. The accumulation of ginsenosideRe [54]in the intestine inhibits the activity of α-glucosidase and promotes the secretion of GLP-1 by L cells as well as the secretion of glucagon.

6. Other Functions

The protective and regenerative effects of TCMs on islet β cells have been utilized in surgical transplantation. Li et al. found extract of trichosanthin [55] could slow reject reaction and protect the transplanted β cells when it was applied in transplantation cases. Serum containing Euonymus fortunei [56] can increase the insulin and GSH content of islet cells, protect the islet cell secretion function, increase the cell survival rate, and reduce ROS-induced islet cell damage before transplantation. Gastrodin (GAS) [57] regulates Nrf2, affects mitochondrial dysfunction, and exhibits antioxidant, anti-inflammatory, and antiapoptotic effects in response to redox damage. Gastrodia elata Blume (GEB) water extract [58] dose-dependently improved hypothalamic insulin signaling, enhanced systemic insulin sensitivity during a euglycemic hyperinsulinemic clamp, and increased insulin secretion under high glucose stimulation. Tangminling (TML) pills [59]mainly contain Rhizoma coptidis, Rheum officinale Baill, Scutellaria baicalensis Georgi, and Bupleurum chinense DC and might improve β cell function in T2DM patients. Tianmai Xiaoke Pian (TMXKP) [60] is composed of Tianhuafen, Maidong, and Wuweizi and could improve ischemia-reperfusion through the PI3K/AKT pathway.

7. Outlook

Type 2 diabetes is characterized by hyperglycaemia due to insulin resistance in peripheral tissues and a defect of β cell function. Many factors have been implicated in β cell dysfunction in T2DM. Traditional Chinese medicine (TCM) has been implicated in practical use in China for thousands of years and has accumulated substantial front-line experience in treating T2DM. In this review, we have highlighted the mechanism of TCMs in protecting β cell function. The current research is mainly focused on improving insulin secretion of β cell, promoting islet cell proliferation, reducing OS damage, and inhibiting apoptosis. The list of the TCM and their role in protective β cell are summarized in Table 1. It is of note that the effects of TCMs on β cell function are mainly evaluated in cellular and rodent models. Whether the effectiveness of improvement of islet β cell function of TCM is shown in animal studies remains unclear. Clinical data are required to access their efficacy and side effects on patients in the future.


TCMFunctionsGenes/proteinsReferences

PuerarinPromotes β cell proliferationPDX-1↑[21]
Reduces islet OS damageMDA↓, activity of SOD↑, PGE2, ET, H2O2, NO levels↓, ICAM-1, NOX2, NOX4 mRNA, and protein expression↓[41]
Oleanolic acidReduces islet OS damageα-glucosidase activity↓[37]
Ginsenoside Rg3Reduces β cell apoptosisPhosphorylation of ERK and p38MAPK↑, P44/42MAPK↓[30]
Rg1SIL-2R↓, CD4/CD8 and NK cell activity↑, autophagy↑, caspase-39↑, Blc2↑[9]
Rb1Reduces islet OS damageJNK pathway↓, JNK1 and c-Jun↓, IL-6, IL-1β, TNF-α[46]
Red ginsengReduces β cell apoptosisBcl-2↑, Bax and the activity of caspase-3↓[31]
Maintains the integrity of the islet structureIslet size↑, insulin immunoreactivity↑, islet boundary was irregular, vacuolization↓
GAPromotes the synthesis and secretion of insulinPTP1BmRNA↓, PPARγ genes and PDX-1↑[9]
Reduces islet OS damageROS↓[45]
BerberinePromotes the synthesis and secretion of insulinThe expression of HNF-1α/PDX-1↑[11]
BaicaleinPromotes the synthesis and secretion of insulinβ cell membrane K+ channel voltage-dependent current↓, intracellular Ca2+ concentration in β cell↓[12]
Promotes β cell proliferationThrough cAMP-mediated mechanism[22]
ResveratrolInduces stem cell differentiation into β cellsThe pluripotent stem cell (hiPSC) MSUH-001 ⟶ β cell[25]
curcuminReduces islet OS damageTLR-4↓, caspase-8↓, GM-CSF, G-CSF, IL-6↓, T cell, NK cell↓[49], [50]
Resveratrol and curcuminPromotes the synthesis and secretion of insulinRegulate the expression and activity of PDEs, cAMP level↑[13]
POP IPromotes β cell proliferationJNK↑, PDX-1, PPARγ, ERK↑[20]
Reduces islet OS damageJNK1, P38, ERK, and RAS proteins in the JNK pathway↓
CPOPReduces islet OS damageMDA content and SOD activity↓[47]
SalidrosidePromotes β cell proliferationInsulin, Pdx-1, GLP-1R mRNA↑IL-1β leve↓[42]
Reduces OS damageTXNIP m RNA↓, TRX m RNA↑, ROS↓[42]
TWPInduces stem cell differentiation into β cellsStem cell ⟶ the cell which expression of β cell functional proteins[24]
SC2Stem cell ⟶ new insulin-secreting cells[26]
ArtemisininInducts islet α cells into β cellsGABA signaling↑, ARX transport from the nucleus to the cytoplasm↓, ARX from chromatin↓, α cell secreting glucagon↓, α ⟶ β cell[29]
PNSReduces β cell apoptosismiR-181b, caspase-3, Bcl-2↑, activation of PI3K-AKT-mTOR pathway↑, Beclin1, LC3-II↓[32]
cortex mori radicisPI3K/Akt↑, caspase-3↓, Bcl-2↑, Bax↓[33]
Ophiopogonis radixNF-kB↓[34]
CSReduces islet OS damageNO production↓, ROS activity↓, Ca2+ concentration↓, UCP-2↑[40]
TFLBSOD, GSH↑; MDA↓[36]
Anoectochilus roxburghiiDPPH, ABTS↓, NO↓; iNOS, COX-2, IL-1β↓[43]
CinnamaldehydeThe antioxidant enzyme activity↑, free radicals↓[44]
MogrosideROS↓GLUT-2, pyruvate kinase gene↑, JNK signal transduction pathway↓FOXO1↓[48]
Polygonatum odoratumIFN-γ, IL-4↓inflammatory cell infiltration↓, the polarization of Th1 cell↓[51]
EmodinPromotes GLP-1 secretionPPARδ, GLP-1↑[53]
TrichosanthinCell transplantation protectionSlow the rejection and protect the transplanted β cells[55]
Euonymus fortuneiCell survival rate↑, ROS induced islet cell damage before transplantation↓[56]
GEBImproving insulin resistanceHypothalamic insulin signaling↑, systemic insulin sensitivity↑[58]

In summary, though great efforts are still needed to better understand its mechanisms and clinical relevance, TCM possesses great potential as a vast and readily available source for finding and developing new drugs to treat T2DM through improving β cells function. With the high prevalence of T2DM in population, it would be beneficial to devote more resources to researching new therapeutic drugs in TCM.

Abbreviations

ABTS:2,2ʹ-Azino-bis (3-ethylbenzothiazoline-6-sulfonic acid)
ATP:Adenosine triphosphate
ATG:Arctigenin
Ber:Berberine
CAT:Catalase
cAMP:Cyclic adenosine monophosphate
Caspase:Cysteinyl aspartate specific proteinase
C-Blc2:B-cell lymphoma-2
COX-2:Cyclooxygenase-2
CPOP:Crude Portulaca oleracea L. polysaccharide
CHM:Chinese herbal medicines
CS:Cordyceps sinensis
DPPH:1,1-diphenyl-2-picrylhydrazyl
ET:Endothelin
ERK:Extracellular regulated protein kinases
Fox 01:Forkhead box protein 01
FYGL:Ganoderma lucidum polysaccharide
GM-CSF:Granulocyte-macrophage-colony-stimulating factor
GSH-Px:Glutathione peroxidase
GLP-1:Glucagon-like peptide1
GAS:Gastrodin
GEB:Gastrodia elata Blume water extract
GLE:Guava leaf extract
GSIS:Glucose-stimulated insulin release test
GA:Guavenoic acid
GLUT4:Glucose transporter 4
GABA:γ-Aminobutyric acid
GSH-Px:Glutathione peroxidase
GSH:Glutathione
HESc:Hydroethanolic extract of S. cumini leaf
HG:High glucose
ICAM-1:Intercellular cell adhesion molecule-1
JQJT:JinQi Jiang Tang
JLD:Jin Li Da
JQ-R:Refined-JQ
MAPK:Mitogen-activated protein kinases
MDA:Malondialdehyde
Myrtaceae:Syzygium cumini (L.) skeels
NF-kB:Nuclear factor-kb
NOX2:Nicotinamide adenine dinucleotide phosphate
PKB:Protein kinase B
PTP1B:Protein tyrosine phosphatase-1B
PPARγ:Peroxisome proliferator-activated receptors
PDX-1:Pancreatic duodenal homeobox-1
PDEs:Phosphodiesterases
POP I:Portulaca oleracea L.
PNS:Panax notoginseng saponins
PTEN:Phosphatase and tensin homolog deleted on chromosome
PGE2:Tenprostaglandin2
ROS:Reactive oxygen species
RNS:Reactive nitrogen species
SOD:Superoxide dismutase
SST:Somatostatin
STZ:Streptozotocin
SC2:Syzygium cumini (L.) skeels
SIL-2R:Soluble interleukin-2 receptor
TCM:Traditional Chinese medicine
TWP:Tripterygium wilfordii polysaccharide
TFLB:Total flavonoids of Lycium barbarum
TMXKP:Tianmai Xiaoke Pian
TML:Tangminling pill
TXNIP:Thioredoxin-interacting protein
TRX:Thioredoxin
TNF-α:Tumor necrosis factor
TLR-4:Toll-like receptors
UCP2:Uncoupling protein 2
XKP:Xiaokeping.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Authors’ Contributions

N. L. wrote the manuscript. H. Z. contributed to discussion and reviewed/edited the manuscript. X. L. contributed to the discussion and reviewed the manuscript.

Acknowledgments

This work was supported by the Shanghai Municipal Health Commission (Grant numbers: zybz-2017021) and Pudong New Area Municipal Health Commission—Summit Clinical Traditional Medicine Grant (Grant numbers: PDZY-2018-0602).

References

  1. X.-L. Tong, L.-H. Zhao, F.-M. Lian et al., “Clinical observations on the dose-effect relationship of Gegen Qin Lian decoction () on 54 out-patients with type 2 diabetes,” Journal of Traditional Chinese Medicine, vol. 31, no. 1, pp. 56–59, 2011. View at: Publisher Site | Google Scholar
  2. X. Sun, L. Guo, H. Shang et al., “The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design,” Trials, vol. 16, no. 1, p. 496, 2015. View at: Publisher Site | Google Scholar
  3. C. Xin, Z. Xia, C. Jiang, M. Lin, and G. Li, “Xiaokeping mixture inhibits diabetic nephropathy in streptozotocin-induced rats through blocking TGF-β1/Smad7 signaling,” Drug Design, Development and Therapy, vol. 9, pp. 6269–6274, 2015. View at: Publisher Site | Google Scholar
  4. S. J. Yue, J. Liu, W. W. Feng et al., “System pharmacology-based dissection of the synergistic mechanism of Huangqi and Huanglian for diabetes mellitus,” Frontiers in Pharmacology, vol. 8, p. 694, 2017. View at: Publisher Site | Google Scholar
  5. X. Y. Li, H. D. Guan, and W. Wang, “Micro RNAs with the regeneration and differentiation of islet β cells and the targeted therapy of traditional Chinese medicine,” Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology, vol. 18, no. 7, pp. 1188–1194, 2016. View at: Google Scholar
  6. S. Jitrapakdee, A. Wutthisathapornchai, J. C. Wallace, and M. J. MacDonald, “Regulation of insulin secretion: role of mitochondrial signalling,” Diabetologia, vol. 53, no. 6, pp. 1019–1032, 2011. View at: Publisher Site | Google Scholar
  7. J. Z. Luo, J. W. Kim, and L. Luo, “Effects of ginseng and its four purifed ginsenosides (Rb2, Re, Rg1, Rd) on human pancreatic islet β cell in vitro,” European Journal of Pharmaceutical and Medical Research, vol. 3, no. 1, pp. 110–119, 2016. View at: Google Scholar
  8. Y. J. Kim, S. M. Park, H. S. Jung et al., “Ginsenoside Rg3 prevents INS-1 cell death from intermittent high glucose stress,” Islets, vol. 8, no. 3, pp. 57–64, 2016. View at: Publisher Site | Google Scholar
  9. M. Jayachandran, R. Vinayagam, R. R. Ambati, B. Xu, and S. S. M. Chung, “Guava leaf extract diminishes hyperglycemia and oxidative stress, prevents β-cell death, inhibits inflammation, and regulates NF-kB signaling pathway in STZ induced diabetic rats,” Biomed Research International, vol. 2018, Article ID 4601649, 14 pages, 2018. View at: Publisher Site | Google Scholar
  10. K. H. Ye, J. R. Wang, J. J. Ma et al., “Promoting effects of guavenoic acid (GA) on proliferation, insulin synthesis and secretion in INS-1 cells and their mechanism,” Chinese Pharmacological Bulletin, vol. 30, no. 12, pp. 1681–1687, 2014. View at: Google Scholar
  11. H. L. Wu, “Protective effects of berberine in pancreatic islet β cells,” Chinese Journal of Pathophysiology, vol. 30, no. 12, pp. 2213–2218, 2014. View at: Google Scholar
  12. Y. Y. Guo, M. M. Liu, X. H. Yang et al., “Effect of baicalein on pancreas insulin secretion in rats and its mechanism,” Chinese Pharmacological Bulletin, vol. 34, no. 6, pp. 820–824, 2018. View at: Google Scholar
  13. M. Rouse, A. Younès, and J. M. Egan, “Resveratrol and curcumin enhance pancreatic β-cell function by inhibiting phosphodiesterase activity,” Journal of Endocrinology, vol. 223, no. 2, pp. 107–117, 2014. View at: Publisher Site | Google Scholar
  14. J. R. Sanches, L. M. Franca, V. T. Chagas et al., “Polyphenol-rich extract of syzygium cumini leaf dually improves peripheral insulin sensitivity and pancreatic islet function in monosodium L-glutamate-induced obese rats,” Frontiers in Pharmacology, vol. 7, p. 48, 2016. View at: Publisher Site | Google Scholar
  15. J. L. Liu, R. Wei, and T. P. Hong, “Implication of proinsulin to insulin ratio in the basic and clinical research of diabetes,” Chinese Journal of Endocrinology and Metabolism, vol. 33, no. 5, pp. 449–452, 2017. View at: Google Scholar
  16. D. Zhu, K. Y. Cai, M. Cao et al., “Proinsulin homeostasis and islet β cell function,” International Journal of Endocrinology and Metabolism, vol. 35, no. 2, pp. 110–113, 2015. View at: Google Scholar
  17. C. Y. Yu, X. Z. Ma, M. Duan, X. H. Chen, and N. Xu, “Effect of Lycium barbarum polysaccharides on ultrastructure of HepG2 cell membrane surface,” Food and Nutrition in China, vol. 19, no. 5, pp. 65–67, 2013. View at: Google Scholar
  18. L. J. Ju, X. H. Wen, and L. Shu, “Study on protective effects of salidrosides on pancreatic β-cell survival,” Journal of Nanjing University of Traditional Chinese Medicine, vol. 32, no. 5, pp. 456–460, 2016. View at: Google Scholar
  19. D. Wang, Z. Ye, and Q. Hang, “Effect and mechanism of cortex Lycii radicis extracts on the proliferation and apoptosis of pancreatic β cell,” Journal of Zhejiang Chinese Medical University, vol. 39, no. 6, pp. 478–481, 2015. View at: Google Scholar
  20. M. Q. Chen, Y. P. Li, G. J. Wu, C. X. Wang, and C. C. Shu, “Inhibitive effects of polysaccharide from Portulaca oleracea L. (POPI) on oxidative damagein INS-1 cells induced by alloxan,” Journal of Jiangxi Science & Technology Normal University, vol. 6, pp. 15–20, 2013. View at: Google Scholar
  21. Z. Li, Z. ShangGuan, Y. Liu, J. Wang et al., “Puerarin protects pancreatic β-cell survival via PI3K/Akt signaling pathway,” Journal of Molecular Endocrinology, vol. 53, no. 1, pp. 71–79, 2014. View at: Publisher Site | Google Scholar
  22. Y. Fu, J. Luo, Z. Jia et al., “Baicalein protects against type 2 diabetes via promoting islet β-cell function in obese diabetic mice,” International Journal of Endocrinology, vol. 2014, Article ID 846742, 13 pages, 2014. View at: Publisher Site | Google Scholar
  23. B. L. Taylor, F.-F. Liu, and M. Sander, “Nkx6.1 is essential for maintaining the functional state of pancreatic β cells,” Cell Reports, vol. 4, no. 6, pp. 1262–1275, 2013. View at: Publisher Site | Google Scholar
  24. Y. H. Cen, Z. H. Li, W. Jia et al., “Tripterygium wilfordii polysaccharide induces differentiation of pancreatic stem cells into islet-like cell clusters,” Chinese Journal of Tissue Engineering Research, vol. 22, no. 5, pp. 729–735, 2018. View at: Google Scholar
  25. D. Pezzolla, J. López-Beas, C. C. Lachaud et al., “Resveratrol ameliorates the maturation process of β-cell-like cells obtained from an optimized differentiation protocol of human embryonic stem cells,” PLoS One, vol. 10, no. 3, Article ID e0119904, 2015. View at: Publisher Site | Google Scholar
  26. M. Dusane and B. N. Joshi, “Seeds of Syzygium cumini (L.) Skeels: potential for islet regeneration in experimental diabetes,” Journal of Chinese Integrative Medicine, vol. 9, no. 12, pp. 1380–1387, 2011. View at: Publisher Site | Google Scholar
  27. S. Y. Cao and L. Yuan, “Pancreatic epithelium may be a new source of islet β cells regeneration,” International Journal of Endocrinology and Metabolism, vol. 35, no. 2, pp. 114–116, 2015. View at: Google Scholar
  28. M. Courtney, E. Gjernes, N. Druelle et al., “The inactivation of arx in pancreatic α-cells triggers their neogenesis and conversion into functional β-like cells,” PLoS Genetics, vol. 9, no. 10, 2013. View at: Publisher Site | Google Scholar
  29. L. Jin, T. Casteels, T. Frogne et al., “Artemisinins target GABAA receptor signaling and impair α cell identity,” Cell, vol. 168, no. 1-2, pp. 86–100, 2017. View at: Publisher Site | Google Scholar
  30. S. S. Kim, H. J. Jang, M. Y. Oh et al., “Ginsenoside Rg3 enhances islet cell function and attenuates apoptosis in mouse islets,” Transplantation Proceedings, vol. 46, no. 4, pp. 1150–1155, 2014. View at: Publisher Site | Google Scholar
  31. S. W. Lim, K. C. Doh, L. Jin et al., “Oral administration of ginseng ameliorates cyclosporine-induced pancreatic injury in an experimental mouse model,” PLoS One, vol. 8, no. 8, p. e72685, 2013. View at: Publisher Site | Google Scholar
  32. M. W. Liu, R. Wei, M. X. Su, H. Li, T. W. Fang, and W. Zhang, “Effects of panax notoginseng saponins on severe acute pancreatitis through the regulation of mTOR/Akt and caspase-3 signaling pathway by upregulating miR-181b expression in rats,” BMC Complementary and Alternative Medicine, vol. 18, no. 1, p. 51, 2018. View at: Publisher Site | Google Scholar
  33. M. Zhang, L. C. OuYang, and M. Long, “Molecular mechanism of cortex mori radicis serum inhibiting apoptosis of islet β cells induced by palmitic acid and high glucose,” Journal of Hubei University of Chinese Medicine, vol. 20, no. 4, pp. 15–17, 2018. View at: Google Scholar
  34. J. P. Sha, H. Y. Ma, X. W. Chen et al., “Influence of ophiopogonis radix on β cell in pancreatic islet of diabetic rats,” Journal of Chengdu University of Traditional Chinese Medicine, vol. 37, no. 3, pp. 23-24, 2014. View at: Google Scholar
  35. Y.-L. Shi, W.-J. Liu, X.-F. Zhang et al., “Effect of Chinese herbal medicine jinlida granule in treatment of patients with impaired glucose tolerance,” Chinese Medical Journal, vol. 129, no. 19, pp. 2281–2286, 2016. View at: Publisher Site | Google Scholar
  36. W. Wang, J. Sang, G. L. Liao, and Y. K. Cu, “Effects of total flavonoids from Lycium barbarum on blood glucose and lipids in rats with type 2 diabetes mellitus,” Chinese Journal of Hospital Pharmacy, vol. 37, no. 1, pp. 17–20, 2017. View at: Google Scholar
  37. H. M. Wang, W. Tian, X. J. La et al., “Regulation of puerarin and oleanolic acid on antioxidant activity and suppressing inflammatory reaction in rats with type 2 diabetes mellitus,” Chinese Journal of Experimental Traditional Medical Formulae, vol. 19, no. 15, pp. 174–177, 2013. View at: Google Scholar
  38. Z. Dong, M. Xu, J. Huang et al., “The protective effect of ginsenoside Rg1 on aging mouse pancreas damage induced by D-galactose,” Experimental and Therapeutic Medicine, vol. 14, no. 1, pp. 616–622, 2017. View at: Publisher Site | Google Scholar
  39. B. Liu, J. Miao, M. Peng, T. Liu, and M. Miao, “Effect of 3 : 7 ratio of astragalus total saponins and curcumin on the diabetic nephropathy rats model,” Saudi Journal of Biological Sciences, vol. 26, no. 1, pp. 188–194, 2019. View at: Publisher Site | Google Scholar
  40. Q. Zheng, H. Liu, D. Y. Cao et al., “Protective effects of cordyceps sinensis on MIN6 cells apoptosis induced by IL-1β and experimental research on the mechanism,” Journal of North Sichuan Medical College, vol. 29, no. 5, pp. 416–420, 2014. View at: Google Scholar
  41. W. Li, W. Zhao, Q. Wu, Y. Lu, J. Shi, and X. Chen, “Puerarin improves diabetic aorta injury by inhibiting NADPH oxidase-derived oxidative stress in STZ-induced diabetic rats,” Journal of Diabetes Research, vol. 2016, Article ID 8541520, 9 pages, 2016. View at: Publisher Site | Google Scholar
  42. M. K. Cui, W. Zhang, Y. Zhao, B. Liu, and Z. Y. Qu, “Effects of salidroside on the function of islet cells cultured under high glucose conditions,” Modern Traditional Chinese Medicine, vol. 35, no. 6, pp. 103–107, 2015. View at: Google Scholar
  43. P. Budluang, P. Pitchakarn, P. Ting, P. Temviriyanukul, A. Wongnoppawich, and A. Imsumran, “Anti-inflammatory and anti-insulin resistance activities of aqueous extract from Anoectochilus burmannicus,” Food Science & Nutrition, vol. 5, no. 3, pp. 486–496, 2017. View at: Publisher Site | Google Scholar
  44. K. D. Li, B. Cang, Z. M. Gu, and W. Wang, “Effect of cinnamic aldehyde on the antioxidant activity in pancreas of db/db mice,” Chinese Journal of Diabetes, vol. 24, no. 8, pp. 738–741, 2016. View at: Google Scholar
  45. J. R. Wang, K. H. Ye, Y. Q. Lv et al., “Effects of guavenoic acid on protection against oxidative damage in INS-1 cells and its mechanisms,” Chinese Pharmaceutical Journal, vol. 50, no. 3, pp. 233–238, 2015. View at: Google Scholar
  46. M. Cao, “Ginsenoside Rb1 ameliorates abnormal glucolipid metabolism of liver through inhibition of JNK signal pathway in diabetic rats,” Chinese Journal of Immunology, vol. 34, no. 4, pp. 536–548, 2018. View at: Google Scholar
  47. Y. Bai, X. Zang, J. Ma, and G. Xu, “Anti-diabetic effect of Portulaca oleracea L. polysaccharideandits mechanism in diabetic rats,” International Journal of Molecular Sciences, vol. 17, no. 8, p. 1201, 2016. View at: Publisher Site | Google Scholar
  48. S. Y. Chen, L. D. Deng, Q. Xu et al., “Mechanism of morgroside intervening in related OS damage of pancreatic islet β cell induced by palmitic acid,” China Pharmacy, vol. 23, no. 23, pp. 2116–2119, 2012. View at: Google Scholar
  49. L. Y. Shi, Y. Liu, W. Chen, F. P. Meng, and Y. Li, “Curcumin antagonized the damage to islet β cells caused by LPS-induced macrophages,” Chinese Journal of Laboratory Diagnosis, vol. 22, no. 2, pp. 310–313, 2018. View at: Google Scholar
  50. R. Ganugula, M. Arora, P. Jaisamut et al., “Nano-curcumin safely prevents streptozotocin-induced inflammation and apoptosis in pancreatic β cells for effective management of type 1 diabetes mellitus,” British Journal of Pharmacology, vol. 174, no. 13, pp. 2074–2084, 2017. View at: Publisher Site | Google Scholar
  51. L. X. Zhang, W. Pang, J. J. Fu, and X. Y. Pan, “Hypoglycemic effect study on streptozotocin induced type 1 diabetes in mice by Polygonatum odoratum,” Pharmacology and Clinics of Chinese Materia Medica, vol. 28, no. 2, pp. 107–110, 2012. View at: Google Scholar
  52. S. C. Wei, L. J. Xu, X. Zou et al., “Preliminary study on secreting effects of Rhizoma Coptidis active ingredients and their combinations on insulin and glucagon-like peptide1 (GLP-1) in glucose feeding mice,” Chinese Journal of Hospital Pharmacy, vol. 37, no. 14, pp. 1343–1347, 2017. View at: Google Scholar
  53. L. C. Zhou, Y. Y. Xu, W. B. Chen et al., “Emodin increase GLP-1 secretion through the activation of PPAR δ,” Chinese Medicine Modern Distance Education of China, vol. 9, no. 21, pp. 142–144, 2011. View at: Google Scholar
  54. J. Gao, S. S. Lu, L. Zhang, and N. Zhou, “Ginsenoside Re promotes glucagons-like-peptide-1 amide secretion in diabetic rats,” Chinese Remedies & Clinics, vol. 11, no. 12, pp. 1383–1385, 2011. View at: Google Scholar
  55. X. F. Li, X. L. Liu, P. Li et al., “Separation and activity observation of the active components of trichosanthin in reducing blood glucose,” Chinese Traditional Patent Medicine, vol. 33, no. 12, pp. 2175–2178, 2011. View at: Google Scholar
  56. P. Jiang, H. J. Gao, J. P. You et al., “Protective effect and mechanism of serum containing Euonymus fortunei on rat pancreatic islet cells,” Organ Transplantation, vol. 9, no. 4, pp. 290–296, 2018. View at: Google Scholar
  57. M. R. de Oliveira, F. B. Brasil, and C. R. Fürstenau, “Evaluation of the mitochondria-related redox and bioenergetics effects of gastrodin in SH-SY5Y cells exposed to hydrogen peroxide,” Journal of Molecular Neuroscience, vol. 64, no. 2, pp. 242–251, 2018. View at: Publisher Site | Google Scholar
  58. H. Yang, M. Kim, D. Kwon et al., “Anti-diabetic activities of gastrodia elata blume water extracts are mediated mainly by potentiating glucose-stimulated insulin secretion and increasing β-cell mass in non-obese type 2 diabetic animals,” Nutrients, vol. 8, no. 3, p. 161, 2016. View at: Publisher Site | Google Scholar
  59. J. Cheng, J. Zheng, Y. Liu, and P. Hao, “Efficacy of traditional Chinese medication Tangminling pill in Chinese patients with type 2 diabetes,” Bioscience Reports, vol. 39, no. 4, Article ID BSR20181729, 2019. View at: Publisher Site | Google Scholar
  60. N. Wang, T. Li, and P. Han, “The effect of tianmai Xiaoke pian on insulin resistance through PI3-K/AKT signal pathway,” Journal of Diabetes Research, vol. 2016, Article ID 9261259, 8 pages, 2016. View at: Publisher Site | Google Scholar

Copyright © 2019 Na Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

649 Views | 346 Downloads | 1 Citation
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.